CRNX vs WAY: Which Stock Is the Better Buy?
Crinetics Pharmaceuticals, Inc. and Waystar Holding Corp. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — CRNX vs WAY, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Crinetics Pharmaceuticals, Inc. (CRNX) | Waystar Holding Corp. (WAY) | |
|---|---|---|
| Market cap | $3.5B | $3.6B |
| Revenue (latest FY) | $7.70M | $1.10B |
| Net income (latest FY) | $-465.32M | $112.09M |
| Revenue growth (5y CAGR) | 155.3% | 16.0% |
| Net margin | -6046.2% | 10.2% |
| Return on equity | -46.9% | 2.9% |
| P/E ratio | — | 28.0 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 1 |
| Positive free cash flow | No | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full CRNX vs WAY breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CRNX's full financials → Open WAY's full financials →More comparisons
Frequently asked questions
Which is bigger, CRNX or WAY?
Waystar Holding Corp. is larger by market capitalization — $3.6B versus $3.5B.
Which grows faster, CRNX or WAY?
Over the last five fiscal years, Crinetics Pharmaceuticals, Inc. grew revenue faster — 155.3%/yr versus 16.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
CRNX fundamentals → · WAY fundamentals → · All 1,500+ companies → · Free screener →